Global ConSeptS – Consultancy is an independent technical consultancy company that was established in 2008. The company specialises in aseptic processing and Quality by Design projects specific to the global bio-pharmaceutical industry. Our approach is pragmatic and to-the-point. You are our customer and we want you to get the best technical solution rather than a theoretical proposal. Although today Global ConSeptS is a one-man company, we want you to be best served. That is why we closely work together with other competent consultancy companies to provide you the best quality for your projects and assure you on-time delivery.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Company Details
Latest Content from PMHub
Press Releases | October 21, 2024 | Innovative Trials
Patient recruitment and retention company, Innovative Trials, was shortlisted as a finalist in the PME Award for its collaboration with US non-profit Oliver Patch Project to improve patient outcomes.
Press Releases | October 18, 2024 | Medscape Education
LONDON--(BUSINESS WIRE)--The Women’s Brain Foundation (WBF), the global pioneer that has advanced the inclusion of sex- and gender-based evidence-generation in all research, drug development, and healthcare since 2017; and Medscape...
Press Releases | October 17, 2024 | Amiculum
We are proud to announce that AMICULUM has achieved the silver award from EcoVadis, a global leader in sustainability assessments, for the second year running! Scoring 73 out of 100,...
Press Releases | October 15, 2024 | Medscape Education
IDWeek starts tomorrow, October 16, and Medscape is bringing outcomes and education! We are excited to announce Medscape is presenting six posters that highlight the significant impact of our educational...
Press Releases | October 15, 2024 | Innovative Trials
Patient Recruitment company, Innovative Trials, appointed new Finance and Business Services Director
Press Releases | October 15, 2024 | Petauri Evidence
• Mtech Access – Powered by Petauri™ are excited to be returning to ISPOR Europe this November. The team will be joined by colleagues from across Petauri, including Delta Hat...
Press Releases | October 14, 2024 | Origins – The Patient Focused Specialists
Last chance to register for our exclusive webinar, “Why Patient Perspectives Matter: Driving Success in Clinical Trials”! Wendy Erler and Alfred Samuels are ready to join Su Smith and...
Press Releases | October 9, 2024 | Medscape Medical Affairs
See more about this new insights product, Medscape AffinityTM, which offers unparalleled insights into the online behaviour of 13M+ HCPs to help you make fully informed decisions around your brand and content...
Press Releases | October 8, 2024 | Origins – The Patient Focused Specialists
Only one week to go until our highly anticipated webinar: “Why Patient Perspectives Matter: Driving Success in Clinical Trials”! We’re thrilled to have Wendy Erler and Alfred Samuels joining...
Videos and Podcasts | October 8, 2024 | Petauri Evidence
What clinical and economic evidence do US payers prefer to drive formulary decisions? How can you optimise your chances of preferential access in the US with the right evidence? How...